Trump strikes major deal with pharma giants Lilly and Novo over obesity drugs, Medicare
NOVEMBER 06, 2025
The administration recognizes that while GLP-1 weight-loss drugs aren't a 'silver bullet,' they're certainly a handy tool in the war against obesity.
No comments:
Post a Comment